Literature DB >> 11796388

Effect of linezolid in comparison with that of vancomycin on glycocalix production: in vitro study.

L Drago, E De Vecchi, M Valli, L Nicola, M R Gismondo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11796388      PMCID： PMC127078          DOI： 10.1128/AAC.46.2.598-599.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  14 in total

1.  Linezolid resistance in a clinical isolate of Staphylococcus aureus.

Authors:  S Tsiodras; H S Gold; G Sakoulas; G M Eliopoulos; C Wennersten; L Venkataraman; R C Moellering; M J Ferraro
Journal:  Lancet       Date:  2001-07-21       Impact factor: 79.321

2.  Coagulase-negative staphylococci isolated from cerebrospinal fluid shunts: importance of slime production, species identification, and shunt removal to clinical outcome.

Authors:  J J Younger; G D Christensen; D L Bartley; J C Simmons; F F Barrett
Journal:  J Infect Dis       Date:  1987-10       Impact factor: 5.226

3.  Effect of extracellular slime substance from Staphylococcus epidermidis on the human cellular immune response.

Authors:  E D Gray; G Peters; M Verstegen; W E Regelmann
Journal:  Lancet       Date:  1984-02-18       Impact factor: 79.321

4.  Linezolid activity compared to those of selected macrolides and other agents against aerobic and anaerobic pathogens isolated from soft tissue bite infections in humans.

Authors:  E J Goldstein; D M Citron; C V Merriam
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

5.  Candida albicans cellular internalization: a new pathogenic factor?

Authors:  L Drago; B Mombelli; E De Vecchi; C Bonaccorso; M C Fassina; M R Gismondo
Journal:  Int J Antimicrob Agents       Date:  2000-12       Impact factor: 5.283

6.  Comparative in vitro activities and postantibiotic effects of the oxazolidinone compounds eperezolid (PNU-100592) and linezolid (PNU-100766) versus vancomycin against Staphylococcus aureus, coagulase-negative staphylococci, Enterococcus faecalis, and Enterococcus faecium.

Authors:  M J Rybak; D M Cappelletty; T Moldovan; J R Aeschlimann; G W Kaatz
Journal:  Antimicrob Agents Chemother       Date:  1998-03       Impact factor: 5.191

7.  Effects of subinhibitory concentrations of vancomycin and teicoplanin on adherence of staphylococci to tissue culture plates.

Authors:  H Carsenti-Etesse; J Durant; J Entenza; V Mondain; C Pradier; E Bernard; P Dellamonica
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

8.  Staphylococcal exopolysaccharides inhibit lymphocyte proliferative responses by activation of monocyte prostaglandin production.

Authors:  R D Stout; K P Ferguson; Y N Li; D W Lambe
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

9.  Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces.

Authors:  G D Christensen; W A Simpson; A L Bisno; E H Beachey
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

10.  Characterization of clinically significant strains of coagulase-negative staphylococci.

Authors:  G D Christensen; J T Parisi; A L Bisno; W A Simpson; E H Beachey
Journal:  J Clin Microbiol       Date:  1983-08       Impact factor: 5.948
View more
  1 in total

1.  Staphylococcus aureus biofilm as a target for single or repeated doses of oxacillin, vancomycin, linezolid and/or lysostaphin.

Authors:  E Walencka; B Sadowska; S Rózalska; W Hryniewicz; B Rózalska
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.099
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.